Hege Hellstrom
Director/Board Member en VIVESTO AB .
Fortuna: 154 254 $ al 31/03/2024
Perfil
Hege Hellstrom is the founder of Belnor BV.
He currently holds the position of Director at Camurus AB, Independent Non-Executive Director at Vivesto AB, Director at Jane Goddall Institute Belgium, Independent Non-Executive Director at InflaRx NV, and Chief Commercial Officer at Advicenne SA. Previously, Hege held the position of General Manager at Genzyme AB, President at Swedish Orphan Biovitrum AB from 2013 to 2018, and Head-Cardiovascular Unit at Sanofi AB.
Hege's education includes an undergraduate degree from Oslo Metropolitan University and Ullevaal School of Bioengineering.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CAMURUS AB
0.01% | 15/09/2023 | 3 250 ( 0.01% ) | 154 254 $ | 31/03/2024 |
Cargos activos de Hege Hellstrom
| Empresas | Cargo | Inicio |
|---|---|---|
| VIVESTO AB | Director/Board Member | 26/09/2019 |
| CAMURUS AB | Director/Board Member | 07/05/2020 |
| ADVICENNE | Corporate Officer/Principal | 26/05/2020 |
| INFLARX N.V. | Director/Board Member | 01/04/2023 |
| Belnor BVBA | Founder | - |
| Jane Goddall Institute Belgium | Director/Board Member | - |
Antiguos cargos conocidos de Hege Hellstrom.
| Empresas | Cargo | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | President | 01/01/2018 |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Corporate Officer/Principal | - |
Genzyme AB
 Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Formación de Hege Hellstrom.
| Oslo Metropolitan University | Undergraduate Degree |
| Ullevaal School of Bioengineering | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| CAMURUS AB | Health Technology |
| VIVESTO AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| ADVICENNE | Health Technology |
| INFLARX N.V. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Health Technology |
Sanofi AB
Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Distribution Services |
| Belnor BVBA | |
| Jane Goddall Institute Belgium |
- Bolsa de valores
- Insiders
- Hege Hellstrom
